« Back to Record
Mayer, E. L., Baurain, J.-F., Sparano, J., Strauss, L., Campone, M., Fumoleau, P., Rugo, H., Awada, A., Sy, O., & Llombart-Cussac, A. (2011). A phase 2 trial of dasatinib in patients with advanced HER2-positive and/or hormone receptor-positive breast cancer. Clinical cancer research, 17(21), 6897-6904. doi:10.1158/1078-0432.CCR-11-0070
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/125886



